Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)

China · Delayed Price · Currency is CNY

26.56

-0.24 (-0.90%)

Apr 9, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing	29.95B	29.27B	30.69B	31.77B	29.21B
Pharmaceutical Manufacturing Growth	2.32%	-4.62%	-3.38%	8.75%	33.14%
Medical Devices and Medical Diagnosis	4.34B	4.35B	4.44B	7.25B	5.97B
Medical Devices and Medical Diagnosis Growth	-0.27%	-2.07%	-38.74%	21.44%	12.91%
Health care Service	7.39B	7.67B	6.71B	6.16B	4.19B
Health care Service Growth	-3.63%	14.28%	9.04%	47.02%	31.59%
Others	209.29M	191.70M	151.06M	156.25M	81.80M
Others Growth	9.18%	26.91%	-3.33%	91.03%	-12.90%
Eliminations	-235.86M	-423.58M	-603.39M	-1.38B	-444.36M
Total	41.66B	41.07B	41.40B	43.95B	39.01B
Total Growth	1.45%	-0.80%	-5.81%	12.66%	28.72%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	28.68B	29.77B	31.03B	30.01B	25.41B
Mainland China Growth	-3.65%	-4.06%	3.38%	18.11%	14.89%
Other Countries or Regions	12.98B	11.30B	10.37B	13.94B	13.60B
Other Countries or Regions Growth	14.87%	8.94%	-25.60%	2.49%	66.08%
Total	41.66B	41.07B	41.40B	43.95B	39.01B
Total Growth	1.45%	-0.80%	-5.81%	12.66%	28.72%

Source: S&P Global Market Intelligence.